Skip to main content
Caplight Logo









Wishbone Biotech

Wishbone Biotech

Private
BelgiumHealthcare & Life Scienceshttps://www.wishbone-biotech.com/

Last Round

Early Funding

Dec 6, 2021

Total Funding Raised

$6.05M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Wishbone Biotech is a medical device company that develops and manufactures bone graft substitute products for bone regeneration and dental implants.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthopedic implantsmedical devicesbone graftbiomaterialsorthobiologicsdental implantsregenerative medicinebovine hydroxyapatitexenograftreconstructive surgerypediatric orthopedicsorthopedic hardwareISO 13485

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wishbone Biotech Comparables

Compare Wishbone Biotech with similar companies based on industry and business-model similarity.

Wishbone Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WishBone Medical, Inc.
78%
Bone Solutions, Inc.
77%
Hydrumedical S.A.
74%

Wishbone Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingDec 6, 2021
Early FundingNov 1, 2021
AcceleratorDec 19, 2013

Key People

Founding team and executive leadership

Emilie Dory

Chief Executive Officer

Executive Team

Wishbone Biotech Investors

Notable investors and investment history

Wishbone Biotech investors
InvestorRounds
NoshaqEarly Funding
EpimedeEarly Funding
Wallonie EntreprendreEarly Funding
The FaktoryEarly Funding, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 54% MoM.

  • Apr 15, 2026

    Monthly visitors increased 53% MoM.

Wishbone Biotech Filings

Explore SEC and related filing metadata, where available.

Wishbone Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Wishbone Biotech's valuation, stock price, and market status.

Is Wishbone Biotech a public or private company?

Wishbone Biotech is a private company.

What is the current stock price of Wishbone Biotech?

Wishbone Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Wishbone Biotech worth (valuation)?

Valuation information for Wishbone Biotech is not publicly available.

Can I buy Wishbone Biotech stock?

Wishbone Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Wishbone Biotech's last funding round?

Wishbone Biotech's most recent funding round was Early Funding on November 1, 2021.

Who are the main investors in Wishbone Biotech?

Key investors in Wishbone Biotech include Wallonie Entreprendre, The Faktory.

Will Wishbone Biotech IPO soon?

No public IPO plans have been announced for Wishbone Biotech.

How can I track Wishbone Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wishbone Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelgium
Employee Range7
Year Founded2013
Last FundingDec 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?